Zoya’s ZoyeMed 3.0 Resilience Edition runs advanced AI on-device with the Amygdala engine to deliver point-of-care diagnostics and continuity of care without internet.
Zoya Technologies Pioneers Offline AI for Uninterrupted Healthcare Access Read More »
How AI is shortening drug discovery timelines, producing real candidates and reshaping R&D with examples from AlphaFold, Exscientia, BenevolentAI and Insilico.
AI’s Proven Track Record: Accelerating Drug Discovery from Lab to Life Read More »
Pacific AI’s CHAI-certified healthcare governance platform is now on AWS and Azure Marketplaces, offering in-tenant data residency, pay-per-credit pricing, and full AI lifecycle controls.
Pacific AI Brings CHAI-Certified Healthcare AI Governance to AWS and Azure Marketplaces Read More »
Puma Biotechnology director Troy Wilson sold 77,748 shares under a 10b5-1 plan amid recent RSU vesting. We break down the trade, Q1 2026 miss, and valuation view.
Puma Biotechnology Director Sells 77,748 Shares as Q1 Results Show Mixed Signals Read More »
A concise update on how AI is reshaping diagnostics, personalized therapies, and proactive care, plus the real-world hurdles and strategic steps for clinical adoption.
AI in Healthcare: From Diagnostics to Collaborative Care Read More »
Multimodal foundation models combine imaging, EHR, and genomics to improve diagnostics, speed drug discovery, and streamline clinical workflows while raising privacy and validation needs.
Multimodal Foundation Models Are Transforming AI in Healthcare Read More »
UK commits £20m to roll out AI for lung cancer detection and £8.1m for wider AI pilots, cutting diagnosis times and targeting national scale by 2029.
NHS scales AI diagnostics with £20m lung cancer rollout and £8.1m pilots Read More »
MFT to launch data platform to support research and patient care.
Manchester University NHS Foundation Trust Launches ADAMS: A New Era for Health Data Read More »
MHRA and NHS England launch the London Region I AI health regulatory sandbox to generate real-world evidence and fast-track safe AI medical devices.
Concise overview of AI in drug discovery: where it delivers, measurable early-stage gains, and the validation and reproducibility hurdles slowing broader adoption.
AI in Drug Discovery: Progress and Persistent Challenges Read More »
